BioTech Investors Investing in the United States

4 investors back BioTech startups in the United States on Startup Fountain.

Startup Fountain is a matching platform for early-stage European startups raising capital. Investors join it themselves and set out what they invest in, so a founder can ask for a warm introduction rather than send a cold email.

This page describes the investors backing BioTech startups in the United States. It is not a scraped directory — everyone counted here chose to be on the platform and can be reached through it. The figures cover all of them; the funds named further down are some of the investors on the platform.

Founders. Raising in BioTech in the United States? These are the investors you could be introduced to. See how it works.

Investors. Investing in BioTech in the United States? This is who else is active, and what they back. See how it works.

BioTech and the United States

BioTech covers startups developing therapeutics, diagnostics, and biological technology platforms. More on BioTech across Europe.

The United States isn't part of Startup Fountain's core European focus, but is tracked given real cross-border activity, including US investors backing European startups. More on the United States.

Key figures

Investors backing BioTech startups in the United States4
Across all countries in BioTech49
Across all industries in the United States16

4 of the 49 BioTech investors on Startup Fountain cover the United States.

How this compares

Frequently asked questions

More about how the platform works on the BioTech page.

What is Startup Fountain?

Startup Fountain is a matching platform for early-stage European startups raising capital. Founders apply once and are matched with investors who have stated they back their sector, stage and country; investors join to see startups that fit the criteria they set. Introductions are made through the platform rather than by cold outreach.

How many investors back BioTech startups in the United States on Startup Fountain?

4 investors have named this as something they invest in and accept introductions for it. The figure counts investors who joined the platform and set their own criteria — it does not include the wider group who only receive deal-flow updates.

What does BioTech cover?

Therapeutics, diagnostics, and biological technology platforms.

Why do BioTech timelines run longer than other categories?

Regulatory approval and clinical validation requirements extend development well beyond typical software or even other hardware timelines.

How do I connect with BioTech investors on Startup Fountain?

Apply as a startup for free, no broker fees, and get matched with vetted investors active in biotech.

Raising in BioTech?

Founders apply once and request warm introductions to the investors counted above, rather than cold-emailing them.

See how Startup Fountain works

An investor yourself? See how the investor side works.

Data as of .